Publicaciones en las que colabora con IDOIA MARTIN GUERRERO (29)

2024

  1. CircRNAome of Childhood Acute Lymphoblastic Leukemia: Deciphering Subtype-Specific Expression Profiles and Involvement in TCF3::PBX1 ALL

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2023

  1. LncRNA-en adierazpen aldakorrak haurren leuzemia linfoblastiko akutuan dituen inplikazioak

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 43, pp. 191-207

  2. The Role of the Dysregulation of Long Non-Coding and Circular RNA Expression in Medulloblastoma: A Systematic Review

    Cancers, Vol. 15, Núm. 19

  3. microRNA sequencing for biomarker detection in the diagnosis, classification and prognosis of Diffuse Large B Cell Lymphoma

    Scientific reports, Vol. 13, Núm. 1, pp. 12159

2022

  1. MicroRNA-based therapeutic strategies for cancer

    MicroRNA: From Bench to Bedside (Elsevier), pp. 503-520

  2. lncRNA deregulation in childhood acute lymphoblastic leukemia: A systematic review

    International journal of oncology, Vol. 60, Núm. 5

2021

  1. A Genome-Wide Study of Single-Nucleotide Polymorphisms in MicroRNAs and Further In Silico Analysis Reveals Their Putative Role in Susceptibility to Late-Onset Alzheimer’s Disease

    Molecular Neurobiology, Vol. 58, Núm. 1, pp. 55-64

  2. Meduloblastoma pediatrikoaren pronostikorako markatzaile molekularren identifikazioa

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 40, pp. 51-76

  3. Prognostic and therapeutic value of somatic mutations in diffuse large B-cell lymphoma: A systematic review

    Critical Reviews in Oncology/Hematology, Vol. 165

  4. Systematic review of the potential of MicroRNAs in the management of patients with follicular lymphoma

    Critical Reviews in Oncology/Hematology, Vol. 159

2020

  1. Role of rs10406069 in miR-5196 in hyperdiploid childhood acute lymphoblastic leukemia

    Epigenomics, Vol. 12, Núm. 22, pp. 1949-1955

  2. Variability in Cerebrospinal Fluid MicroRNAs Through Life

    Molecular Neurobiology, Vol. 57, Núm. 10, pp. 4134-4142

2019

  1. Cell-free DNA as a biomarker in diffuse large B-cell lymphoma: A systematic review

    Critical Reviews in Oncology/Hematology, Vol. 139, pp. 7-15

2018

  1. Involvement of miRNA polymorphism in mucositis development in childhood acute lymphoblastic leukemia treatment

    Pharmacogenomics, Vol. 19, Núm. 18, pp. 1403-1412

2017

  1. The miR-1206 microRNA variant is associated with methotrexate-induced oral mucositis in pediatric acute lymphoblastic leukemia

    Pharmacogenetics and Genomics, Vol. 27, Núm. 8, pp. 303-306

2016

  1. Lack of association of the CEP72 RS924607 TT genotype with vincristine-related peripheral neuropathy during the early phase of pediatric acute lymphoblastic leukemia treatment in a Spanish population

    Pharmacogenetics and Genomics, Vol. 26, Núm. 2, pp. 100-102

  2. Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia

    Pharmacogenomics, Vol. 17, Núm. 7, pp. 731-741

2015

  1. Erratum to: Potential relationship between single nucleotide polymorphisms used in forensic genetics and diseases or other traits in European population[Int J Legal Med (2015) 129,435-443, DOI 10.1007/s00414-015-1165-7]

    International Journal of Legal Medicine

  2. Genetic variants in MiRNA processing genes and Pre-MiRNAs are associated with the risk of chronic lymphocytic leukemia

    PLoS ONE, Vol. 10, Núm. 3

  3. Polymorphisms in miRNA processing genes and their role in osteosarcoma risk

    Pediatric Blood and Cancer, Vol. 62, Núm. 5, pp. 766-769